Trial intelligence / Profile preview

High Dose Vitamin D3 in Craniotomy Patients

NCT03248544Completed

Sponsor
Shahid Beheshti University
Start
Jul 2017
Primary completion
Jul 2018
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Randomised, double-blind trial of vitamin d in brain neoplasms (2 arms), sponsored by Shahid Beheshti University. Primary endpoint: Vitamin D level. Started Jul 2017; status: completed.

02

Drugs

vitamin d
03

Conditions

brain neoplasms

Beyond the preview

Go deeper on NCT03248544.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03248544.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call